1991
DOI: 10.1021/jm00113a011
|View full text |Cite
|
Sign up to set email alerts
|

Folate analogs. 35. Synthesis and biological evaluation of 1-deaza, 3-deaza, and bridge-elongated analogs of N10-propargyl-5,8-dideazafolic acid

Abstract: Structural modifications at the pyrimidine ring and at the C9,N10-bridge region of the thymidylate synthase (TS) inhibitors N10-propargyl-5,8-dideazafolate (1; PDDF; CB 3717), 2-desamino-N10-propargyl-5,8-dideazafolate (2, DPDDF), and 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolate (3, DMPDDF) have been carried out. Methods for the synthesis of 2-desamino-N10-propargyl-1,5,8-trideazafolate (4), 2-desamino-2-methyl-N10-propargyl-3,5,8-trideazafolate (5a), and 2-desamino-2-methyl-N10-propargyl-5,8-dideaza-1,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
21
0

Year Published

1996
1996
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(21 citation statements)
references
References 2 publications
0
21
0
Order By: Relevance
“…Reaction of 2-bromo-N-phenylbenzamide (4) with malononitrile (2 b) to lead to 3-amino-1,2-dihydro-1-oxo-2-phenylisoquinoline-4-carbonitrile (5).…”
Section: Resultsmentioning
confidence: 99%
“…Reaction of 2-bromo-N-phenylbenzamide (4) with malononitrile (2 b) to lead to 3-amino-1,2-dihydro-1-oxo-2-phenylisoquinoline-4-carbonitrile (5).…”
Section: Resultsmentioning
confidence: 99%
“…Substituted isoquinolones are orally effective antagonists of receptors 5-HT 3 (Matsui et al, 1992), thymidylate synthase inhibitors (Li et al, 1991), human tumour necrosis factor inhibitors and tachykinin receptors (Chao et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…Generally, quinolinones and their derivatives contain many biologically active alkaloids and can serve as bases in nucleosides or building units in the synthesis of many alkaloids. [11] Many methods, which are very important in synthetic and medicinal chemistry, have been developed. [12] However, in our research, isoquinolinones 2, which are different from biologically active quinolinones, are a family of conjugated heterocyclic compounds.…”
Section: Introductionmentioning
confidence: 99%